...
首页> 外文期刊>Bioorganic and medicinal chemistry >Novel 3 H -1,2,3triazolo4,5- c pyridine derivatives as GPR119 agonists: Synthesis and structure-activity/solubility relationships
【24h】

Novel 3 H -1,2,3triazolo4,5- c pyridine derivatives as GPR119 agonists: Synthesis and structure-activity/solubility relationships

机译:Novel 3 H -1,2,3triazolo4,5- c pyridine derivatives as GPR119 agonists: Synthesis and structure-activity/solubility relationships

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Graphical abstract Display Omitted Abstract We previously reported a novel series of 1 H -pyrazolo[3,4- c ]pyridine derivatives and the identification of compound 4b as a highly potent GPR119 agonist. However, the advancement of preclinical evaluations of compound 4b is expected to be difficult because of the compound’s significantly poor aqueous solubility (0.71 μM at pH6.8). In this article, we describe the further optimization of compound 4b focusing on the improvement of its aqueous solubility. Optimization of the central spacer, left-hand aryl group and right-hand piperidine N -capping group led to the identification of a potent GPR119 agonist, 3 H -[1,2,3]triazolo[4,5- c ]pyridine derivative 32o , with improved solubility (15.9 μM at pH6.8). ]]>

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号